Stock of the Day

Revelation Biosciences (REVB)

$0.85

+$0.03 (+3.8%)

Market Cap: $0.80M

About Revelation Biosciences

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.

The company was founded in 2020 and is based in San Diego, California.

Recent News

• Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering (finance.yahoo.com)
• Revelation Biosciences sets terms for $4 million public offering (investing.com)